ACC 21 Discussion: The RADIANCE-HTN TRIO Trial

Published: 16 May 2021

  • Views:

    Views Icon 673
  • Likes:

    Heart Icon 0
Average (ratings)
No ratings
Your rating

Dr Ajay Kirtane (Columbia University Medical Center, New York, NY, US) joins host, Dr Harriette Van Spall (McMaster University, Hamilton, CA) to discuss the findings from the Randomized Sham-controlled RADIANCE-HTN TRIO Trial.

The study assessed the efficacy and safety of endovascular ultrasound renal denervation in patients with hypertension resistant to three or more antihypertensive medications.

Recorded remotely from New York and Hamilton, 2021.

Editor: Mirjam Boros

Videography:Mike Knight